Reapplix executive pleased with board scoop: "A great match"

The recently resigned CEO of the medical device company Mölnlycke joins Reapplix' board, through which the company gains the exact skills needed for its current US venture, according to both chairman and CEO.

Reapplix Chairman Ulrik Spork Photo: Reapplix / PR

"A great match."

These are the chairman of Danish company Reapplix Ulrik Spork's words to describe the new US board member Richard Twomey, who, after six years working as the CEO in a leading medical solutions company, has agreed to advise and counsel the pharmaceutical firm on its path to success based on the company's biological band-aids for the treatment of diabetic foot ulcers.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Related articles